K002674Substantially Equivalent
Randox Microalbumin
Randox Laboratories, Limited, Crumlin, Co. Antrim, IE / Traditional, Substantially Equivalent
K002674 is the FDA 510(k) clearance record for RANDOX MICROALBUMIN, a class II device, cleared for Randox Laboratories, Ltd. on under FDA product code DDZ (Albumin, Fitc, Antigen, Antiserum, Control). FDA records list 134 510(k) clearances for Randox Laboratories, Ltd., from to . As of , FDA records show one recall naming K002674.
Clearance record
- Decision date
- Received
- (38 days to decision)
- Product code
- DDZ Albumin, Fitc, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5040
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Randox Laboratories, Ltd. 55 Diamond Rd., Crumlin, Co. Antrim, IE
- 510(k) summary
- Statement
- Third party review
- No
Clearances, product code DDZ
Trailing 12 monthsFDA records hold no clearances under product code DDZ in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
